Stay updated on Nivolumab Ipilimumab Metastatic Uveal Melanoma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Ipilimumab Metastatic Uveal Melanoma Clinical Trial page.

Latest updates to the Nivolumab Ipilimumab Metastatic Uveal Melanoma Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check27 days agoChange DetectedAdded revision v3.5.0 and removed revision v3.4.3.SummaryDifference0.1%

- Check34 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check62 days agoChange DetectedRevision tag updated to v3.4.2 and the previous funding/status notice (v3.4.1) was removed. The core study details remain unchanged.SummaryDifference0.4%

- Check69 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and updated the page version from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check76 days agoChange DetectedShow glossary is now visible and the QC criteria label has been updated to 'Last Update Submitted that Met QC Criteria'. The footer now includes 'No FEAR Act Data' and a revision note 'Revision: v3.4.0'.SummaryDifference0.2%

- Check90 days agoChange DetectedFooter now displays Revision: v3.3.4, replacing Revision: v3.3.3.SummaryDifference0.1%

Stay in the know with updates to Nivolumab Ipilimumab Metastatic Uveal Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Ipilimumab Metastatic Uveal Melanoma Clinical Trial page.